Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition from Eli Lilly’s Zepbound and Mounjaro.

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

Christina Aguilera has lost her famous curves – and weight loss drug Ozempic is to blame, with the pop superstar now barely ...

Pharma giant Novo Nordisk, the company behind Wegovy and Ozempic, expects to launch six products in the next five years. Leading the pack of new drugs will be CagriSema.

New industry rules require visual size checks or GP medical records for online fat jab purchases. The updated guidelines ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Berberine, a plant-based compound, is being touted as a potential aid for weight loss, blood sugar control, and heart health, ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Around half a million Britons are now thought to be using the medication, which can help them lose up to 20 per cent of their ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...